Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aduhelm (aducanumab)
Marketing
Eisai's Leqembi launch tripped up on a host of challenges
Neurologists are voicing “frustration” at core elements of Leqembi's rollout.
Ben Adams
Feb 27, 2024 9:20am
Eisai's Leqembi gaining ground with US neurologists
Apr 11, 2023 10:00am
Eisai breaks down early days for Alzheimer's med Leqembi
Feb 6, 2023 10:04am
Eisai and Biogen's lecanemab wins FDA backing in Alzheimer's
Jan 6, 2023 2:22pm
Biogen is ready to roll on lecanemab production, CFO says
Oct 25, 2022 11:06am
Biogen is reportedly homing in on a pick for its next CEO
Oct 7, 2022 2:07pm
